UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2011
VENTAS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 1-10989 | 61-1055020 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
111 S. Wacker Drive, Suite 4800, Chicago, Illinois |
60606 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (877) 483-6827
Not applicable |
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On July 1, 2011, Ventas, Inc. (the Company) held a special meeting of stockholders (the Special Meeting) to vote upon certain matters relating to the Companys acquisition of Nationwide Health Properties, Inc., a Maryland corporation (NHP).
Proxies for the Special Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. Set forth below are the voting results for the proposals considered and voted upon at the Special Meeting, all of which were described in the Companys definitive Proxy Statement, filed with the Securities and Exchange Commission on May 16, 2011:
1. | The issuance of shares of the Companys common stock to stockholders of NHP in connection with the merger contemplated by the Agreement and Plan of Merger, dated as of February 27, 2011, by and among the Company, its wholly owned subsidiary, Needles Acquisition LLC, and NHP. |
For | Against | Abstain | Broker Non-Votes | |||
164,944,040 | 168,600 | 108,152 | |
2. | The amendment of the Companys Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Companys capital stock from 310,000,000 to 610,000,000 and the number of authorized shares of the Companys common stock from 300,000,000 to 600,000,000. |
For | Against | Abstain | Broker Non-Votes | |||
164,507,587 | 606,907 | 106,298 | |
3. | Any adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes for the proposals to issue shares of the Companys common stock in connection with the merger and the charter amendment to increase the number of authorized shares of the Companys common stock. |
For | Against | Abstain | Broker Non-Votes | |||
154,300,549 | 10,609,969 | 310,274 | |
VENTAS, INC. | ||||
Date: July 1, 2011
|
By: | /s/ T. Richard Riney | ||
T. Richard Riney Executive Vice President, Chief Administrative Officer and General Counsel |